Nextcure Inc (NXTC)

10:54 AM

What analysts say about NextCure Inc. stockSuperior investment outcomes - Autocar Professional

10:54 AM

07:27 AM

NextCure Inc. Stock Analysis and ForecastFree Predictions - Autocar Professional

07:27 AM

Jul 22, 2025

What drives NextCure Inc. stock priceExceptional return forecasts - jammulinksnews.com

Jul 22, 2025

Jul 21, 2025

Is NextCure Inc. a good long term investmentHigh-octane financial growth - Autocar Professional

Jul 21, 2025

Jul 16, 2025

What makes NextCure Inc. stock price move sharplyConsistent Growth Alert - Newser

Jul 16, 2025

Jul 16, 2025

Why NextCure Inc. stock attracts strong analyst attentionFree Access to Community - Newser

Jul 16, 2025

Jul 15, 2025

How NextCure Inc. stock performs during market volatilitySecure Your Capital Strategy - Newser

Jul 15, 2025

Jul 15, 2025

Piper Sandler lowers NextCure stock price target to $15 after reverse split By Investing.com - Investing.com South Africa

Jul 15, 2025

Jul 15, 2025

Piper Sandler lowers NextCure stock price target to $15 after reverse split - Investing.com India

Jul 15, 2025

Jul 14, 2025

NextCure initiates one-for-twelve reverse stock split on Nasdaq By Investing.com - Investing.com Nigeria

Jul 14, 2025

Jul 14, 2025

NextCure Implements Reverse Stock Split on Nasdaq - TipRanks

Jul 14, 2025

Jul 14, 2025

NextCure initiates one-for-twelve reverse stock split on Nasdaq - Investing.com

Jul 14, 2025

Jul 10, 2025

NextCure Announces One-for-Twelve Reverse Stock Split - TipRanks

Jul 10, 2025

Jul 10, 2025

NextCure announces 1-for-12 reverse stock split effective July 14 - Investing.com Nigeria

Jul 10, 2025

Jul 10, 2025

NextCure announces 1-for-12 reverse stock split effective July 14 By Investing.com - Investing.com South Africa

Jul 10, 2025

Jul 06, 2025

Analysts Offer Insights on Healthcare Companies: NextCure (NXTC), Lexaria Bioscience (LEXX) and Travere Therapeutics (TVTX) - The Globe and Mail

Jul 06, 2025

Jul 02, 2025

NextCure’s (NXTC) Buy Rating Reaffirmed at HC Wainwright - Defense World

Jul 02, 2025

Jun 23, 2025

Eyes on Asia: AstraZeneca, NextCure, Sagimet Biosciences - BioXconomy

Jun 23, 2025

Jun 17, 2025

Nextcure Inc: Analyzing NXTC Stock Trends - investchronicle.com

Jun 17, 2025

Jun 17, 2025

Market Recap: Next Technology Holding Inc (NXTT)’s Positive Momentum, Closing at 1.40 - DWinneX

Jun 17, 2025

Jun 17, 2025

Market Highlights: Nextcure Inc (NXTC) Ends on a Low Note at 0.50 - DWinneX

Jun 17, 2025

Jun 17, 2025

NextCure tanks as it teams up with Simcere on novel ADC - The Pharma Letter

Jun 17, 2025

Jun 17, 2025

NextCure and Simcere partner to develop SIM0505 for solid tumours - Yahoo Home

Jun 17, 2025

Jun 16, 2025

NextCure partners with Simcere Zaiming on cancer drug development By Investing.com - Investing.com South Africa

Jun 16, 2025

Jun 16, 2025

NextCure Joins China-ADC Gold Rush with $745M Simcere Deal - BioSpace

Jun 16, 2025

Jun 16, 2025

NextCure Inks $745M Deal With Simcere For Cancer Drug: Retail’s More Optimistic Despite Stock’s 27% Decline - Asianet Newsable

Jun 16, 2025

Jun 16, 2025

NextCure And Simcere Zaiming Partner To Develop CDH6-Targeting ADC SIM0505 For Solid Tumors - Nasdaq

Jun 16, 2025

Jun 16, 2025

NextCure signs up to $745 million deal with China's Simcere to develop cancer drug - MarketScreener

Jun 16, 2025

Jun 16, 2025

Simcere Pharmaceutical's Unit Enters Into License Agreement With Nextcure - marketscreener.com

Jun 16, 2025

Jun 16, 2025

NextCure Enters Licensing Agreement with Simcere Zaiming - TipRanks

Jun 16, 2025

Jun 16, 2025

NextCure (NXTC) Partners with Simcere Zaiming for Innovative Cancer Treatment | NXTC Stock News - GuruFocus

Jun 16, 2025